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1. Introduction 
Gynecomastia is derived from the Greek terms gynec (feminine) and mastos (breast). The 
literal translation, male breasts, relates to any condition that results in excessive 
development of breast tissue in males.  
Galen introduced the term gynecomastia in the second century AD. He defined 
gynecomastia as an unnatural increase in the breast fat of males. The first recorded 
description of a reduction mammaplasty was by Paulas of Aegina in the seventh century 
AD, who referred to the condition as an "effeminacy of men."  
Gynecomastia is responsible for a significant amount of emotional and psychological 
trauma especially in the young population. The treatment of gynecomastia has continued to 
evolve over the ages and today needs to be designed specifically to address the amount of 
skin excess, glandular breast tissue, adipose tissue, degree of breast ptosis, and the size of 
the nipple areolar complex (NAC). Each component should be considered separately to 
optimize the outcome.  
2. Incidence 
The increase in breast size due to the accumulation of fatty tissue, as seen in obese patients, 
is considered pseudogynecomastia. True gynecomastia may or may not be associated with 
pathologic conditions as this can be the result of the usual physiologic development. 
Prevalence of asymptomatic gynecomastia is 60%–90% in neonates, 50%–60% in adolescents, 
and up to 70% in men age 50–69 years. [1-3] Trimodal distribution for asymptomatic 
gynecomastia is noted (neonatal, pubertal, and in elderly males). Prevalence of symptomatic 
gynecomastia is markedly lower.  
Physiologic gynecomastia is common in adolescents at the time of puberty with published 
incidence rates of 25 to 65% by the ages of 14. [4] By the time pubertal changes are 
completed and hormonal levels stabilized the persistence of gynecomastia is uncommon. 
Different series report between 30% and 50% incidence although in adolescent populations 
the incidence of bilateral gynecomastia could be even higher.[5] 
Previous studies have reported that in an average out-patient clinic you may see 10 to 20 
new cases of gynecomastia per year, accounting for up to 80% of all male breast referrals. [2, 
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3, 6, 7] In a recent study the referrals for specialist evaluation for gynecomastia have 
increased 500% since 1990’s making this pathology more prevalent.[8] 
3. Pathophysiology 
The hormonal role of estrogen/testosterone ratio has been identified as a cause of 
gynecomastia although many other reasons were identified as possible causes of 
gynecomastia (Table 1).  Is important to rule out any other pathologic process related to 
gynecomastia, in particular testicular sources. A thorough interrogation should be 
performed including family history as well as relevant medications, recreational drugs, etc. 
 
Physiologic  
Neonatal 
Puberty 
Advance age 
Familial 
 
Androgen deficiency 
Hypogonadism 
  Primary 
     Klinefelter’s syndrome 
     Kallman’s syndrome 
     Congenital anorchia 
     ACTH deficiency 
     Defects in androgen 
      systhesis 
   Secondary 
      Trauma 
      Orchitis 
      Cryptorchidism 
      Irradiation 
      Hydrocele 
      Spermatocele 
      Varicocele 
Renal failure 
Exogenous Androgens 
 
Estrogen excess 
  Testucular soruces 
     Germ cell tumors  
     Choriocarcinoma 
     Seminoma 
     Teratoma 
  Non-germ cell tumors 
     Leydig cell tumor 
     Granulaosa-theca tumor 
     Sertoli cell tumor 
 
True Hermaphroditism 
Liver disease 
Exogenous estrogen 
Malnutrition 
Drugs 
Alcohol 
Amphetamines 
Chemotherapeutic agents 
Cimetidine 
Digitalis 
Haldol 
Hydroxyzine 
Isoniazid 
Methyldopa 
Marijuana 
Opiates 
Phenothiazines 
Progestins 
Reserpine 
Spironolactone 
Tricyclinc antidepressants 
 
 
Systemic Conditions / 
idiopathic  
 
       Obesity 
Hyperthyroidism 
Hypothyroidism 
Chronic illness 
AIDS 
 
 
Neoplastic 
    Breast carcinoma 
    Liver carcinoma 
    Lung carcinoma 
    Adrenal tumors 
 
 
Infectious 
 
Sparganum or 
plerocercoid larva of the 
tapeworm 
 
 
Table 1. Causes of Gynecomastia 
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Symmetrical and bilateral breast enlargement is usually the result of both glandular and 
adipose tissue enlargement. In those cases where a unilateral or asymmetrical involvement 
is noted a thorough diagnostic investigation should be done to rule out breast carcinoma, 
where a breast biopsy is indicated. 
4. Indications and contraindications 
Considering that gynecomastia is a cause of emotional and psychological distress is 
important to clearly identify the main concern for the patient in the context of development. 
Many times is just a matter of aesthetic concern but other circumstances such as pain, 
tenderness, and even the possibility of cancer should be considered. Reassurance and 
guidance play an important role in the adolescent population during puberty. Watchful 
waiting during these years is an accepted practice.  
All patients undergoing gynecomastia should be optimized to avoid complications. 
NSAID’s should be stopped one week prior to the procedures and resumed one week after 
the procedure if necessary. No patients on therapeutic anticoagulation should be treated for 
this condition. Smoking is relative contraindications but is our practice to require smoking 
cessation for at least two weeks prior to the procedure and four weeks after the procedure. 
Contraindications for gynecomastia include patients with: 
 cardiopulmonary disease 
 renal failure 
 therapeutic anticoagulation 
 wound-healing problems 
 immunodeficiency 
 active smokers 
 morbid obesity 
5. Patient evaluation and selection 
A complete evaluation is necessary to identify the cause of the pathology, optimize the 
timing for surgery, rule out neoplastic origin, and avoid unnecessary interventions.  
Physical examination should include bilateral breast exams as well as neck and axillary 
bimanual palpation to rule out any masses or adenopathies. A bilateral testicular 
examination should be included.  
Any palpable mass, especially in asymmetric enlargement should undergo biopsy to rule 
out malignancy.  
Laboratory evaluation should follow physical findings and patients should be appropriately 
referred to an endocrinologist as needed.  
6. Medical management 
Neonatal and puberal gynecomastia are usually self limiting and often do not require any 
type of treatment. Less than 10% of adolescent will experience persistent breast enlargement 
that will require some kind of intervention. On the other hand, gynecomastia of advanced 
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age does not resolve spontaneously and often requires treatment.  Several drugs have been 
used in the treatment of gynecomastia for different reasons. Clomiphene, an antiestrogen 
has been utilized and reported since 1970’s by multiple authors [9-11].  The androgen 
Danazole has also been used with success [12-14]. Testosterone supplementation for cases of 
testosterone deficiency has been used. Most recently Tamoxifen has been used with some 
success[15-17]. Even radiation has been reported in the past. 
Medical treatment of gynecomastia is usually applied during the first stages of the disease 
as a palliative method to control symptoms such as pain and tenderness while surgical 
management is usually the method of choice to address the aesthetic concern. 
7. Surgical management 
The surgical management of gynecomastia has evolved considerably over the last 60 years. 
Since the first descriptions by Webster in 1946 [18], the subsequent classifications by Simon 
in 1973[19],  and the introduction of liposuctions for gynecomastia in 1983 [20] a broad 
spectrum of alternatives developed to address the multiple degrees of this condition. The 
subsequent advances in technologies and minimally invasive techniques allowed for a more 
refined approach to the condition. Based on this Dr. Rohrich expanded the classification and 
management alternatives in 2003. [21] 
7.1 Considerations  
There are certain characteristics that need to be addressed when planning a surgical 
approach to gynecomastia. These characteristics are: 
 Amount of skin excess and skin quality 
 Adipose component 
 Glandular component 
 Size of nipple areolar complex 
Amount of skin excess and skin quality 
The skin envelope plays a significant role in determining which will be the preferred 
approach. As outlined in Table-2 and Table-3, Dr. Rohrich modification of the original 
Simon classification serves as a guide for treatment. In cases with minimal skin excess and 
good skin quality a minimally invasive approach should suffice. This includes liposuction 
and perhaps limited skin incisions such as periareolar, intra-areolar, transaxilary, and 
edoscopic for excision of breast tissue. When the skin envelope is enlarged and/or stretched 
such as in postbariatric population, or in moderate to severe cases of gynecomastia, a larger 
excision should be planned.  
The position of the nipple areolar complex (NAC) is also an important factor and will 
determine if a minimally invasive approach will be sufficient, or a mastopexy, and even a 
free nipple graft, will be required.  
The different methods to address a significant skin excess and ptosis include crescentic 
excision, periareolar mastopexy, vertical mastopexy, Wise pattern mastopexy and 
inframammary fold scar. Crescentic mastopexy will allow for minimal mobilization up to 1 
cm of the NAC in a cephalad direction. At the same time allows for access for direct excision 
of the breast tissue. This method is reserved for cases with mild to moderate ptosis and good 
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skin quality. Periareolar mastopexy can be utilized also when a mild amount of excess skin 
is to be excised allowing for better access to excision of breast tissue. Vertical mastopexy can 
address cases of moderate ptosis allowing a comfortable access for removal of breast tissue. 
This method could be used for moderate to severe cases where skin excision and NAC 
repositioning form 1 to 5 cm is required. Wise pattern mastopexy is usually reserved for 
cases where a significant amount of excess tissue is to be removed. This approach also 
allows for an open access for removal of breast tissue and at the same time allows for easy 
repositioning of the NAC. The scars resulting from this procedure are usually the limiting 
factor as patients prefer a less invasive approach. The inframammary fold scar allows a large 
resection of excess tissue with a transverse scar along the inframammary fold but often 
requires free nipple graft for transposition of the NAC.   
Adipose component 
The amount of adipose tissue plays an important role on the method required to address the 
gynecomastia. The main line of treatment for adipose tissue is suction assisted liposuction 
(SAL). Some patients may present with dense fibrous septi within the adipose tissue. In 
these cases ultrasound assisted liposuction (UAL) or power assisted liposuction (PAL) in 
combination with SAL delivers the best result. If the adipose component is the main cause of 
gynecomastia, liposuction alone or combined with a minimal access excision should be the 
preferred option.  
Glandular component 
If the glandular component of the breast is prevalent the fibrous architecture becomes the main 
concern. Liposuction techniques alone are often insufficient to completely address the issue 
and a direct excision of some kind is required. While SAL still play a significant role in 
addressing the adipose tissue and sculpting of the periphery, the central glandular component 
should be excised. Some authors advocate a minimally invasive approach either by 
performing minimal access incisions in the periphery of the NAC or using arthroscopic 
shavers as a mean to break down the fibrous capsule of the glandular component and retrieve 
it with conventional liposuction methods.[22] If skin excess is also a significant concern, direct 
excision becomes the method of choice as the access is granted by the larger skin incisions.  
Size of the nipple areolar complex 
In some cases the diameter of the NAC is too large and other times there is a significant 
asymmetry between the sizes of the NACs. In either of these circumstances a reduction of 
the NAC is required. A periareolar incision is performed and the excess tissue is removed 
reducing the diameter of the NAC. This procedure can also be performed in combinations 
with either of the mastopexy techniques described above.  
 
Classification Clinical Features Treatment Options 
Grade I Breast fullness without ptosis Excision plus liposuction 
Grade II Breast fullness with the nipple at the IMF Excision, liposuction and 
nipple transposition 
Grade III Significant hypertrophy with the nipple 
below the IMF 
Breast reduction with 
nipple transposition 
Table 2. Classification of Gynecomastia 
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Classification Clinical Features Treatment Options 
Grade I: Minimal 
hypertrophy, less than 250 g. 
IA: Primarily fatty breast 
tissue 
IB: Primarily fibrous breast 
tissue 
Suction assisted lipectomy 
(SAL)  is highly successful 
Additional excision is often 
required 
Grade II: Moderate 
hypertrophy, 250 to 500 g. 
IIA: Primarily fatty breast 
tissue 
IIB: Primarily fibrous breast 
tissue with peripheral fat 
SAL is highly effective 
Usually requires central 
excision with peripheral 
suction 
Grade III: Severe 
hypertrophy, more than 500 g. 
Severe hypertrophy with 
grade I ptosis 
Requires resection with 
suction 
Grade IV: Severe 
Hypertrophy with grade II or 
III ptosis 
Severe hypertrophy with 
grade II or III ptosis 
Requires resection with 
suction and possible nipple 
transposition. 
Table 3. Rohrich Classification of Gynecomastia 
7.2 Operative technique 
Markings are made to outline the boundaries of treatment. The inframammary fold is also 
marked preoperatively with the patient standing. Further markings for NAC repositioning 
are performed with the patient in the upright position.  All patients undergo general 
anesthesia and are positioned supine with the arms abducted. The entire chest wall and 
upper abdomen are included in the operative field. Appropriate antibiotic and deep venous 
thrombosis prophylaxis are used.  
Liposuction 
Suction assisted liposuction alone or in combination with UAL and PAL play an essential 
role in the treatment of pseudogynecomastia or those cases where mild gynecomastia is 
present with a predominant adipose component. Our preferred technique includes 
infiltration of the surgical area with superwet solution (1:1 ratio) with a solution containing 
50 ml of 1% lidocaine, and one ampule of 1:1000 epinephrine in 1 liter of lactated Ringer’s 
solution. A remote access at the anterior axilary line is used for a 3-4 mm liposuction canula.  
Following the initial conventional SAL the UAL is used to address the areas of dense tissues. 
Ultrasound-assisted liposuction is first performed using the LySonix 3000 Ultrasonic Surgical 
Aspirator System (Byron Medical, Tucson, Ariz.). It is set on the pulse mode at amplitude of 90 
percent. A plastic port is placed into the incision through which the ultrasound probe is 
passed. The endpoint for ultrasound application is loss of tissue resistance throughout the 
marked area (approximately 4 to 10 minutes per side). We do not perform PAL although it is a 
viable alternative. The skin flaps are thinned to a thickness of approximately 1.5 cm.  Extra 
SAL is utilized if further refinements are necessary after UAL. Sequential pressure with a 
rolled gauze-sponge is applied at the end of the procedure to evacuate the excess of fluid 
through the access ports. The ports are sutured and a compression garment is applied.  
Liposuction and endoscopic excision of breast tissue 
Liposuction is usually performed as previously explained. The transaxilary approach is used 
for the excision of the breast tissue. Similarly to the approach for transaxilary breast 
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augmentation, a tunnel is developed and the breast tissue including adipose and glandular 
tissue are excised under direct visualization using and endoscopic guidance. This technique 
is reserved for conditions where there is no need for repositioning of the NAC and good 
skin quality. 
Liposuction with direct excision and repositioning of the nipple areola complex 
Liposuction is performed as explained above and once completed the direct excision and NAC 
repositioning are undertaken following the preoperative markings. If no NAC repositioning is 
required a minimal access direct excision is performed through an inferior periareolar incision. 
The authors find that the morbidity of this approach is minimal and, at the same time, more 
efficient and cost effective than other minimally invasive techniques described. Case 1 
Case 1 
Grade II gynecomastia treated with periareolar approach with liposuction (SAL and UAL) 
followed by direct excision of breast tissue – Preop and 6 months follow up. 
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Wise pattern and inframammary approach with or without free nipple graft 
This is the treatment of choice for the severe ptosis and the massive weight loss patient. In 
some cases a radical resection with free nipple grafting is necessary and delivers the best 
results to those patients with Grade III or severe gynecomastia. In these cases we favour an 
inframammary approach with resection of excess skin, subcutaneous and glandular tissue 
and repositioning of the NAC as a free NAC graft. The position of the new NAC is 
determined once the excision has been undertaken and the flaps approximated with staples. 
The new NAC position is deepithelialized and the free nipple graft sawn into position with 
a bolster dressing. Case 2 
Case 2 
Grade III gynecomastia on a massive weight loss patient. Treatment included 
inframmamary fold approach with direct excision of excess skin and breast tissue followed 
by free nipple graft. Preop and one month follow up. 
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The algorithm on Figure 1 demonstrates our propose treatment plan for the different 
degrees of gynecomastia 
 
 
 
 
Fig. 1. 
7.3 New developments 
Laser assisted liposuction 
Laser assisted liposuction has been described. The adjunct of laser therapy facilitates the 
lipolysis process without undue risk. [23, 24] 
Dermoglandular repositioning for re-contouring of the masculine chest 
Resection of breast an adipose tissue is not always the answer to gynecomastia. With the 
new developments and techniques in body contouring a new path for the treatment of 
gynecomastia has emerged. Some cases of gynecomastia require a reshaping procedure 
more than an ablative one. Although not yet published, we would like to present a case that 
illustrates this concept. Case 3. On a weight loss patient with gynecomastia a 
dermoglandular flap containing the NAC was fashioned and repositioned. The resulting 
shape of the chest contour shows restoration of the masculine contour of the anterior chest 
wall, where an ablative procedure would have resulted in a flat appearance.  
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Case 3 
Grade I gynecomastia with caudal displacement of the NAC following weight loss. 
Treatment included dissection and repositioning of the NAC based on a dermoglandular 
flap. Preop intraop and post operative pictures are shown. 
   
   
 
 
 
 
 
 
POSTOPT1 POSTOPT2 POSTOPT3 
8. Postoperative care 
All patients received compression garment treatment for six weeks to minimize the 
formation of seromas and avoid dead space. Those patients that undergo a large excision 
with wide undermining get drained for approximately 10 to 14 days. Patients are advised to 
refrain from strenuous activity for a period of 4 weeks with a recovery time of 7 to 10 days 
before returning to regular activities.  We strongly believe a compliant postoperative course 
has a significant impact in speed of recovery and avoidance of complications.  
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9. Complications 
The development of seromas is the number one complication. Often times and despite the 
rigorous measures to avoid seromas the dead space created by liposuction is prone to 
subsequent accumulation of fluid that needs to be drained during the follow up period. 
Hematomas are much less frequent with an incidence under 1%. Infection is uncommon but 
would healing complications can be a problem, especially in those cases with a large 
resection and free nipple grafting. The avoidance of undue tension and the use of drain 
and/or quilting sutures may help to decrease the common misadventures of the 
postoperative period. Skin necrosis and skin damage from aggressive liposuction, 
ultrasound liposuction, or arthroscopic shaver use have been reported. These complications 
are due to technical errors and should be avoided by the use of a consistent and careful 
technique.  
10. Conclusion 
Gynecomastia is a condition with increase prevalence and the advent of new developments 
and techniques require a dynamic update to deliver the best possible outcome. Several 
options are available today to address the different degrees of gynecomastia. The careful 
analysis of individual patients will permit the selection of the appropriate treatment method 
to deliver the best result. Psychological guidance plays an important role in the treatment of 
the condition. 
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